drugset / Trial / NCT04174937
PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers
Phase 1
Completed
72 enrolled
Scientific Center for Anti-infectious Drugs, Kazakhstan
Al-Farabi Kazakh National University · collabInstitute Of Cardiology & Internal Diseases, Kazakhstan · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
This is a first-in-human (FIH) study to explore the safety, tolerability and pharmacokinetics of PA after oral ascending dose administration to healthy male volunteers.
Timeline
- Start
- 2016-06-17
- Primary completion
- 2019-05-15
- Completion
- 2019-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Potentiator of antibiotics (PA) | Unknown | 1 mg/ml | Oral |